IDEXX Laboratories Announces Second Quarter Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/14/2026
- Nasdaq ends down as chipmakers fall and bank earnings roll in
- Oil prices settle mixed, focus on US-Russia diesel deal, Saudi Yemen attacks
- JPMorgan shares edge lower after third-quarter FICC revenue miss
- Fed’s Waller says US bond yield rise driven by growth, not inflation
- Wells Fargo beats profit estimates despite revenue miss
IDEXX Laboratories (IDXX) PT Raised to $785 at Jefferies
August 5, 2025 6:21 AM EDTJefferies analyst Keith Devas raised the price target on IDEXX Laboratories (NASDAQ: IDXX) to $785.00 (from $625.00) while maintaining a Buy rating.
The analyst comments "Strong 2Q results (sales +10.6%, EBITDA +14%) and higher guidance confirms the innovation playbook is working. Management's decision to pull-forward spend in... More



